Recent Finacing
Recent Raise
Surv BioPharma is a Japan-based biotech developing survivin-promoter–driven oncolytic adenoviruses that selectively destroy cancer cells, targeting rare and refractory tumors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
